GI Dynamics announces Institutional Review Board approval for EndoBarrier pivotal trial

Image: GI Dynamics has received Institutional Review Board approval to conduct its pivotal trial of EndoBarrier for type 2 diabetes and obesity. Photo: courtesy of dream designs / FreeDigitalPhotos.net.